TONIX PHARMACEUTICALS
Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring, and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is primarily composed of the central nervous system (CNS) and immunology product candidates. The CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions.
TONIX PHARMACEUTICALS
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2007-11-16
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.tonixpharma.com
Total Employee:
11+
Status:
Active
Contact:
212-980-9155
Email Addresses:
[email protected]
Total Funding:
257.84 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Font Awesome
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Broadfin Capital
Broadfin Capital investment in Post-IPO Equity - Tonix Pharmaceuticals
Sabby Management
Sabby Management investment in Post-IPO Equity - Tonix Pharmaceuticals
Deerfield
Deerfield investment in Post-IPO Equity - Tonix Pharmaceuticals
Technology Partners
Technology Partners investment in Post-IPO Equity - Tonix Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-09 | Tonix Pharmaceuticals Announces Appointment of Jeffrey Rosenfeld, Ph.D., as Executive Director, Genomics and Bioinformatics |
Official Site Inspections
http://www.tonixpharma.com Semrush global rank: 1.74 M Semrush visits lastest month: 13.64 K
- Host name: gra.graphicainc.com
- IP address: 162.241.142.33
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
